Skip to main content
Profusa, Inc. logo

Profusa, Inc. — Investor Relations & Filings

Ticker · PFSA ISIN · US66718N1037 US Manufacturing
Filings indexed 248 across all filing types
Latest filing 2025-08-18 Proxy Solicitation & In…
Country US United States of America
Listing US PFSA

About Profusa, Inc.

https://profusa.com/

Profusa, Inc. is a digital health and medical technology company that develops tissue-integrating biosensors for continuous monitoring of body chemistries. The company's core technology consists of highly miniaturized, injectable sensors designed to minimize the foreign body response, enabling long-term, real-time transmission of clinical-grade data. Its primary product, the Lumee™ Oxygen Platform, is a wireless system that continuously measures tissue oxygen levels. Profusa's solutions are aimed at advancing personalized medicine, telehealth, and remote patient monitoring for conditions such as chronic limb-threatening ischemia. The company's mission is to make the body's chemistry easily accessible to improve health and wellness.

Recent filings

Filing Released Lang Actions
PROXY STATEMENT
Proxy Solicitation & Information Statement
2025-08-18 English
AMENDMENT NO. 1 TO FORM 8-K
Regulatory Filings
2025-08-14 English
QUARTERLY REPORT
Interim / Quarterly Report Q2 2025
2025-08-14 English
REGISTRATION STATEMENT
Registration Form
2025-08-09 English
PROXY STATEMENT
Regulatory Filings
2025-08-08 English
CURRENT REPORT
Regulatory Filings
2025-08-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.